Global Niraparib Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 306864
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Niraparib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Niraparib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Recurrent Epithelial Ovarian Cancer accounting for % of the Niraparib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 100mg*30 Capsules segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Niraparib include TESARO, Everest Pharmaceuticals Limited, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Niraparib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

100mg*30 Capsules

100mg*60 Capsules

100mg*90 Capsules

Market segment by Application can be divided into

Recurrent Epithelial Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cancer

Other

The key market players for global Niraparib market are listed below:

TESARO

Everest Pharmaceuticals Limited

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Niraparib product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Niraparib, with price, sales, revenue and global market share of Niraparib from 2019 to 2022.

Chapter 3, the Niraparib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Niraparib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Niraparib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Niraparib.

Chapter 13, 14, and 15, to describe Niraparib sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Niraparib Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Niraparib Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 100mg*30 Capsules

1.2.3 100mg*60 Capsules

1.2.4 100mg*90 Capsules

1.3 Market Analysis by Application

1.3.1 Overview: Global Niraparib Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Recurrent Epithelial Ovarian Cancer

1.3.3 Fallopian Tube Cancer

1.3.4 Primary Peritoneal Cancer

1.3.5 Other

1.4 Global Niraparib Market Size & Forecast

1.4.1 Global Niraparib Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Niraparib Sales in Volume (2017-2028)

1.4.3 Global Niraparib Price (2017-2028)

1.5 Global Niraparib Production Capacity Analysis

1.5.1 Global Niraparib Total Production Capacity (2017-2028)

1.5.2 Global Niraparib Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Niraparib Market Drivers

1.6.2 Niraparib Market Restraints

1.6.3 Niraparib Trends Analysis

2 Manufacturers Profiles

2.1 TESARO

2.1.1 TESARO Details

2.1.2 TESARO Major Business

2.1.3 TESARO Niraparib Product and Services

2.1.4 TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Everest Pharmaceuticals Limited

2.2.1 Everest Pharmaceuticals Limited Details

2.2.2 Everest Pharmaceuticals Limited Major Business

2.2.3 Everest Pharmaceuticals Limited Niraparib Product and Services

2.2.4 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Niraparib Breakdown Data by Manufacturer

3.1 Global Niraparib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Niraparib Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Niraparib

3.4 Market Concentration Rate

3.4.1 Top 3 Niraparib Manufacturer Market Share in 2021

3.4.2 Top 6 Niraparib Manufacturer Market Share in 2021

3.5 Global Niraparib Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Niraparib Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Niraparib Market Size by Region

4.1.1 Global Niraparib Sales in Volume by Region (2017-2028)

4.1.2 Global Niraparib Revenue by Region (2017-2028)

4.2 North America Niraparib Revenue (2017-2028)

4.3 Europe Niraparib Revenue (2017-2028)

4.4 Asia-Pacific Niraparib Revenue (2017-2028)

4.5 South America Niraparib Revenue (2017-2028)

4.6 Middle East and Africa Niraparib Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Niraparib Sales in Volume by Type (2017-2028)

5.2 Global Niraparib Revenue by Type (2017-2028)

5.3 Global Niraparib Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Niraparib Sales in Volume by Application (2017-2028)

6.2 Global Niraparib Revenue by Application (2017-2028)

6.3 Global Niraparib Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Niraparib Sales by Type (2017-2028)

7.2 North America Niraparib Sales by Application (2017-2028)

7.3 North America Niraparib Market Size by Country

7.3.1 North America Niraparib Sales in Volume by Country (2017-2028)

7.3.2 North America Niraparib Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Niraparib Sales by Type (2017-2028)

8.2 Europe Niraparib Sales by Application (2017-2028)

8.3 Europe Niraparib Market Size by Country

8.3.1 Europe Niraparib Sales in Volume by Country (2017-2028)

8.3.2 Europe Niraparib Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Niraparib Sales by Type (2017-2028)

9.2 Asia-Pacific Niraparib Sales by Application (2017-2028)

9.3 Asia-Pacific Niraparib Market Size by Region

9.3.1 Asia-Pacific Niraparib Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Niraparib Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Niraparib Sales by Type (2017-2028)

10.2 South America Niraparib Sales by Application (2017-2028)

10.3 South America Niraparib Market Size by Country

10.3.1 South America Niraparib Sales in Volume by Country (2017-2028)

10.3.2 South America Niraparib Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Niraparib Sales by Type (2017-2028)

11.2 Middle East & Africa Niraparib Sales by Application (2017-2028)

11.3 Middle East & Africa Niraparib Market Size by Country

11.3.1 Middle East & Africa Niraparib Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Niraparib Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Niraparib and Key Manufacturers

12.2 Manufacturing Costs Percentage of Niraparib

12.3 Niraparib Production Process

12.4 Niraparib Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Niraparib Typical Distributors

13.3 Niraparib Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Niraparib Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Niraparib Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. TESARO Basic Information, Manufacturing Base and Competitors

Table 4. TESARO Major Business

Table 5. TESARO Niraparib Product and Services

Table 6. TESARO Niraparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Everest Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors

Table 8. Everest Pharmaceuticals Limited Major Business

Table 9. Everest Pharmaceuticals Limited Niraparib Product and Services

Table 10. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Global Niraparib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)

Table 12. Global Niraparib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 13. Market Position of Manufacturers in Niraparib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 14. Global Niraparib Production Capacity by Company, (K Pcs): 2020 VS 2021

Table 15. Head Office and Niraparib Production Site of Key Manufacturer

Table 16. Niraparib New Entrant and Capacity Expansion Plans

Table 17. Niraparib Mergers & Acquisitions in the Past Five Years

Table 18. Global Niraparib Sales by Region (2017-2022) & (K Pcs)

Table 19. Global Niraparib Sales by Region (2023-2028) & (K Pcs)

Table 20. Global Niraparib Revenue by Region (2017-2022) & (USD Million)

Table 21. Global Niraparib Revenue by Region (2023-2028) & (USD Million)

Table 22. Global Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 23. Global Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 24. Global Niraparib Revenue by Type (2017-2022) & (USD Million)

Table 25. Global Niraparib Revenue by Type (2023-2028) & (USD Million)

Table 26. Global Niraparib Price by Type (2017-2022) & (USD/Pcs)

Table 27. Global Niraparib Price by Type (2023-2028) & (USD/Pcs)

Table 28. Global Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 29. Global Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 30. Global Niraparib Revenue by Application (2017-2022) & (USD Million)

Table 31. Global Niraparib Revenue by Application (2023-2028) & (USD Million)

Table 32. Global Niraparib Price by Application (2017-2022) & (USD/Pcs)

Table 33. Global Niraparib Price by Application (2023-2028) & (USD/Pcs)

Table 34. North America Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 35. North America Niraparib Sales by Country (2023-2028) & (K Pcs)

Table 36. North America Niraparib Revenue by Country (2017-2022) & (USD Million)

Table 37. North America Niraparib Revenue by Country (2023-2028) & (USD Million)

Table 38. North America Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 39. North America Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 40. North America Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 41. North America Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 42. Europe Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 43. Europe Niraparib Sales by Country (2023-2028) & (K Pcs)

Table 44. Europe Niraparib Revenue by Country (2017-2022) & (USD Million)

Table 45. Europe Niraparib Revenue by Country (2023-2028) & (USD Million)

Table 46. Europe Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 47. Europe Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 48. Europe Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 49. Europe Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 50. Asia-Pacific Niraparib Sales by Region (2017-2022) & (K Pcs)

Table 51. Asia-Pacific Niraparib Sales by Region (2023-2028) & (K Pcs)

Table 52. Asia-Pacific Niraparib Revenue by Region (2017-2022) & (USD Million)

Table 53. Asia-Pacific Niraparib Revenue by Region (2023-2028) & (USD Million)

Table 54. Asia-Pacific Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 55. Asia-Pacific Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 56. Asia-Pacific Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 57. Asia-Pacific Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 58. South America Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 59. South America Niraparib Sales by Country (2023-2028) & (K Pcs)

Table 60. South America Niraparib Revenue by Country (2017-2022) & (USD Million)

Table 61. South America Niraparib Revenue by Country (2023-2028) & (USD Million)

Table 62. South America Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 63. South America Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 64. South America Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 65. South America Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 66. Middle East & Africa Niraparib Sales by Region (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Niraparib Sales by Region (2023-2028) & (K Pcs)

Table 68. Middle East & Africa Niraparib Revenue by Region (2017-2022) & (USD Million)

Table 69. Middle East & Africa Niraparib Revenue by Region (2023-2028) & (USD Million)

Table 70. Middle East & Africa Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 71. Middle East & Africa Niraparib Sales by Type (2023-2028) & (K Pcs)

Table 72. Middle East & Africa Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 73. Middle East & Africa Niraparib Sales by Application (2023-2028) & (K Pcs)

Table 74. Niraparib Raw Material

Table 75. Key Manufacturers of Niraparib Raw Materials

Table 76. Direct Channel Pros & Cons

Table 77. Indirect Channel Pros & Cons

Table 78. Niraparib Typical Distributors

Table 79. Niraparib Typical Customers

List of Figures

Figure 1. Niraparib Picture

Figure 2. Global Niraparib Revenue Market Share by Type in 2021

Figure 3. 100mg*30 Capsules

Figure 4. 100mg*60 Capsules

Figure 5. 100mg*90 Capsules

Figure 6. Global Niraparib Revenue Market Share by Application in 2021

Figure 7. Recurrent Epithelial Ovarian Cancer

Figure 8. Fallopian Tube Cancer

Figure 9. Primary Peritoneal Cancer

Figure 10. Other

Figure 11. Global Niraparib Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028

Figure 12. Global Niraparib Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Niraparib Sales (2017-2028) & (K Pcs)

Figure 14. Global Niraparib Price (2017-2028) & (USD/Pcs)

Figure 15. Global Niraparib Production Capacity (2017-2028) & (K Pcs)

Figure 16. Global Niraparib Production Capacity by Geographic Region: 2022 VS 2028

Figure 17. Niraparib Market Drivers

Figure 18. Niraparib Market Restraints

Figure 19. Niraparib Market Trends

Figure 20. Global Niraparib Sales Market Share by Manufacturer in 2021

Figure 21. Global Niraparib Revenue Market Share by Manufacturer in 2021

Figure 22. Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 23. Top 3 Niraparib Manufacturer (Revenue) Market Share in 2021

Figure 24. Top 6 Niraparib Manufacturer (Revenue) Market Share in 2021

Figure 25. Global Niraparib Sales Market Share by Region (2017-2028)

Figure 26. Global Niraparib Revenue Market Share by Region (2017-2028)

Figure 27. North America Niraparib Revenue (2017-2028) & (USD Million)

Figure 28. Europe Niraparib Revenue (2017-2028) & (USD Million)

Figure 29. Asia-Pacific Niraparib Revenue (2017-2028) & (USD Million)

Figure 30. South America Niraparib Revenue (2017-2028) & (USD Million)

Figure 31. Middle East & Africa Niraparib Revenue (2017-2028) & (USD Million)

Figure 32. Global Niraparib Sales Market Share by Type (2017-2028)

Figure 33. Global Niraparib Revenue Market Share by Type (2017-2028)

Figure 34. Global Niraparib Price by Type (2017-2028) & (USD/Pcs)

Figure 35. Global Niraparib Sales Market Share by Application (2017-2028)

Figure 36. Global Niraparib Revenue Market Share by Application (2017-2028)

Figure 37. Global Niraparib Price by Application (2017-2028) & (USD/Pcs)

Figure 38. North America Niraparib Sales Market Share by Type (2017-2028)

Figure 39. North America Niraparib Sales Market Share by Application (2017-2028)

Figure 40. North America Niraparib Sales Market Share by Country (2017-2028)

Figure 41. North America Niraparib Revenue Market Share by Country (2017-2028)

Figure 42. United States Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Niraparib Sales Market Share by Type (2017-2028)

Figure 46. Europe Niraparib Sales Market Share by Application (2017-2028)

Figure 47. Europe Niraparib Sales Market Share by Country (2017-2028)

Figure 48. Europe Niraparib Revenue Market Share by Country (2017-2028)

Figure 49. Germany Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Niraparib Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Niraparib Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Niraparib Sales Market Share by Region (2017-2028)

Figure 57. Asia-Pacific Niraparib Revenue Market Share by Region (2017-2028)

Figure 58. China Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Korea Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Niraparib Sales Market Share by Type (2017-2028)

Figure 65. South America Niraparib Sales Market Share by Application (2017-2028)

Figure 66. South America Niraparib Sales Market Share by Country (2017-2028)

Figure 67. South America Niraparib Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East & Africa Niraparib Sales Market Share by Type (2017-2028)

Figure 71. Middle East & Africa Niraparib Sales Market Share by Application (2017-2028)

Figure 72. Middle East & Africa Niraparib Sales Market Share by Region (2017-2028)

Figure 73. Middle East & Africa Niraparib Revenue Market Share by Region (2017-2028)

Figure 74. Turkey Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Egypt Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. South Africa Niraparib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Manufacturing Cost Structure Analysis of Niraparib in 2021

Figure 79. Manufacturing Process Analysis of Niraparib

Figure 80. Niraparib Industrial Chain

Figure 81. Sales Channel: Direct Channel vs Indirect Channel

Figure 82. Methodology

Figure 83. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz